(a) Identification.
         A C-peptides of proinsulin test system is a device intended to measure C-peptides of proinsulin levels in serum, plasma, and urine. Measurements of C-peptides of proinsulin are used in the diagnosis and treatment of patients with abnormal insulin secretion, including diabetes mellitus.
     
    
        
        (b) Classification.
         Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of  part 807 of this chapter subject to  § 862.9.
     
    
        
            Code of Federal Regulations
        
        [52 FR 16122, May 1, 1987, as amended at 65 FR 2305, Jan. 14, 2000]